HomeADIL • NASDAQ
Adial Pharmaceuticals Inc
add
$0.33
0.97%
After Hours:(1.77%)-0.0058
$0.32
Closed: Jul 3, 4:58:13 PM UTC-4 · USD · NASDAQ · Disclaimer
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.27M | 22.89% |
Net income | -2.23M | 65.59% |
Net profit margin | — | — |
Earnings per share | -0.34 | 50.09% |
EBITDA | -2.27M | -22.89% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.37M | -52.92% |
Total assets | 3.45M | -48.37% |
Total liabilities | 1.32M | 135.36% |
Total equity | 2.13M | — |
Shares outstanding | 7.90M | — |
Price to book | 1.03 | — |
Return on assets | -133.45% | — |
Return on capital | -183.00% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -2.23M | 65.59% |
Cash from operations | -1.59M | 2.51% |
Cash from investing | 150.00K | — |
Cash from financing | 50.65K | -98.68% |
Net change in cash | -1.38M | -163.00% |
Free cash flow | -786.74K | 17.80% |
Previous close
$0.33
Day range
$0.32 - $0.35
Year range
$0.22 - $3.00
Market cap
5.16M USD
Avg Volume
15.50M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2010
Headquarters
Website
Employees
5
